Minocycline cream for a rare skin condition
Part of Skin clinical trials.
This trial tests whether a cream containing minocycline can help treat a rare skin condition called CARP. The cream is applied directly to the skin, and the study aims to see if it reduces the skin changes without the side effects of oral medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 9 years old.
- You have been diagnosed with CARP (a skin condition that causes dark, velvety patches).
- You have not taken oral minocycline in the last 6 months.
- You are not pregnant or breastfeeding.
- You do not have a history of increased pressure in the brain, autoimmune disease, liver or kidney disease, or a weakened immune system.
- You are not allergic to tetracycline antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a common antibiotic called minocycline can slow the vision loss caused by retinitis pigmentosa. It is a randomized, double-blind study, meaning neither you nor your doctor will know if you are getting the real drug or a placebo (inactive pill). If it works, it could help preserve your remaining vision.
This study tests a cream called benvitimod to see if it helps treat a type of skin lymphoma (mycosis fungoides). It may help control skin symptoms with less harsh side effects than other treatments.
This trial tests a cream called ruxolitinib for people with dermatomyositis whose skin symptoms haven't improved with standard treatments. It aims to see if this cream can reduce rash and activity when added to your current medications.
This trial is testing a cream called tofacitinib (a type of medicine that helps calm the immune system) for people with early-stage cutaneous T-cell lymphoma (CTCL). The goal is to see if it helps shrink or control the skin lesions safely.
This trial studies whether rapamycin can reduce problems caused by cervico-facial or chest (mediastinal) lymphatic malformations in children. It may help with pain and swallowing or breathing difficulties when standard “curative” treatment isn’t possible.
This study tests a cream that targets inflammation in the skin for people with early-stage mycosis fungoides, a type of lymphoma. It may help relieve symptoms and slow the disease without stronger treatments.
Hear when a new Confluent and Reticulated Papillomatosis (CARP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.